VIVO VENTURES VII LLC 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 8:46 pm Sale | 2024-09-30 | 13G | Verona Pharma plc VRNA | VIVO VENTURES VII LLC | 20,252,688 3.100% | -2,889,512 (-12.49%) | Filing |
| 2023-02-13 5:47 pm Purchase | 2022-12-31 | 13G | Verona Pharma plc VRNA | VIVO VENTURES VII LLC | 23,142,200 3.800% | 23,142,200 (New Position) | Filing |